‘Disappointed’ UCB And Amgen Will Appeal CHMP’s Negative Evenity Decision

 
• By Sten Stovall
  
Osteoporosis
CHMP rejection contrasts with FDA's approval of Evenity in April • Source: Shutterstock

More from Business

More from Scrip